Skip to main content

TransMedics Group, Inc.

corporate_fare Company Profile

TransMedics Group, Inc.

TMDX·NASDAQ·Industrial Applications And Services·CIK 0001756262

We are a medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the Organ Care System (OCS) to replace a decades-old standard of care. Our OCS technology replicates many aspects of the organ's natural living and functioning environment outside of the human body, transforming organ preservation for transplantation from a static state to a dynamic environment that enables organ optimization and assessment. We also developed our National Organ Procurement (NOP), a turnkey solution providing outsourced organ procurement, OCS perfusion management, and transplant logistics services, including aviation transportation, ground transportation, and other coordination activity, to transplant programs in the United States. We designed the OCS as a platform to leverage core technologies across products for multiple organs. To date, we have developed three OCS products: OCS Heart, OCS Lung, and OCS Liver. The OCS is the only FDA approved, portable, multi-organ, warm perfusion technology platform. All three products have received Pre-Market Approval (PMA) from the FDA for both organs donated after brain death (DBD organs) and organs donated after circulatory death (DCD organs). Organ transplantation is the treatment for end-stage organ failure, but transplant volumes have been restricted by the limitations of cold storage, the standard of care for solid organ transplantation.

TransMedics Group, Inc. (NASDAQ:TMDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for TMDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 13 rated 8 or above. Recent SEC coverage for TMDX spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • Shares Surge 25% as Q3 Beat and Raised 2026 Outlook Land
  • TransMedics 10-Q Discloses Inventory-Related Material Weakness Alongside Record Q3 Revenue
  • TransMedics Q3 Revenue Jumps 41% to $203M, Full-Year Guidance Raised to $764-$774M
  • TransMedics Posts $17.1M Third-Quarter Net Income
  • TransMedics Q2 Revenue Beats, But Net Income Drops on R&D Spend

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$605.49M
Net Income
$190.29M
Diluted EPS
$4.87
Op. Cash Flow
$192.84M
Free Cash Flow
$133.59M
Gross Profit
$362.81M
Operating Income
$108.58M
Cash & Equivalents
$488.37M
Total Debt
$462.8M
Debt / Equity
0.98×
Net Margin
31.4%
Shares Outstanding
34.27M sh
Source: 10-K · filed 2026-02-24 · accession 0001193125-26-067032

Short Interest & Short Volume

10.22 days to cover

FINRA reported short interest of 8,877,506 shares in TMDX as of the October 30, 2026 settlement, a 1.2% increase from the prior period — about 10.2 days to cover at its recent average daily volume. On November 20, 2026, 55.4% of TMDX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)8,877,506 shares as of October 30, 2026
Change vs prior period▲ 1.2%
Days to cover10.22 at avg daily volume of 869,058
Daily short volume (FINRA facilities)55.4% of 612,327 shares on November 20, 2026
5-day average short volume61.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$85.6 +0.41% today
52-week range · as of 2026-11-05 $60.1 – $156
Market cap
$2.96B
Volume
1.6M (1.4× avg)
3-mo avg 1.2M
Live data · 2026-11-21 23:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TMDX - Latest Insights

TMDX
Nov 06, 2026, 2:06 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $87.77
Real-time Price: $85.60 info
Change: -$2.17 (-2%) info
Market Cap: $2.961B info
TMDX
Nov 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $85.60 info
Change: +$3.10 (+4%) info
Market Cap: $2.961B info
TMDX
Nov 05, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.80
Real-time Price: $85.60 info
Change: +$8.80 (+11%) info
Market Cap: $2.961B info
TMDX
Nov 05, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $68.97
Real-time Price: $85.60 info
Change: +$16.63 (+24%) info
Market Cap: $2.961B info
TMDX
Aug 04, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $88.04
Real-time Price: $85.60 info
Change: -$2.44 (-3%) info
Market Cap: $2.961B info
TMDX
Aug 04, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $88.50
Real-time Price: $85.60 info
Change: -$2.90 (-3%) info
Market Cap: $2.961B info
TMDX
Aug 04, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $88.00
Real-time Price: $85.60 info
Change: -$2.40 (-3%) info
Market Cap: $2.961B info
TMDX
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.01
Real-time Price: $85.60 info
Change: +$3.59 (+4%) info
Market Cap: $2.961B info
TMDX
May 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $68.85
Real-time Price: $85.60 info
Change: +$16.75 (+24%) info
Market Cap: $2.961B info
TMDX
May 07, 2026, 4:50 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $72.59
Real-time Price: $85.60 info
Change: +$13.01 (+18%) info
Market Cap: $2.961B info
TMDX
May 05, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $72.51
Real-time Price: $85.60 info
Change: +$13.09 (+18%) info
Market Cap: $2.961B info
TMDX
May 05, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $77.33
Real-time Price: $85.60 info
Change: +$8.27 (+11%) info
Market Cap: $2.961B info
TMDX
Apr 29, 2026, 9:27 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $101.70
Real-time Price: $85.60 info
Change: -$16.10 (-16%) info
Market Cap: $2.961B info
TMDX
Apr 10, 2026, 7:48 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $109.10
Real-time Price: $85.60 info
Change: -$23.50 (-22%) info
Market Cap: $2.961B info
TMDX
Feb 27, 2026, 8:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $133.30
Real-time Price: $85.60 info
Change: -$47.70 (-36%) info
Market Cap: $2.961B info
TMDX
Feb 27, 2026, 7:03 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $133.30
Real-time Price: $85.60 info
Change: -$47.70 (-36%) info
Market Cap: $2.961B info
TMDX
Feb 24, 2026, 4:16 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $147.03
Real-time Price: $85.60 info
Change: -$61.43 (-42%) info
Market Cap: $2.961B info
TMDX
Feb 24, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $139.68
Real-time Price: $85.60 info
Change: -$54.08 (-39%) info
Market Cap: $2.961B info
TMDX
Feb 04, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $130.37
Real-time Price: $85.60 info
Change: -$44.77 (-34%) info
Market Cap: $2.961B info
TMDX
Jan 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $138.30
Real-time Price: $85.60 info
Change: -$52.70 (-38%) info
Market Cap: $2.961B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets